Case Report: Genomic characterization of a rare skull-base plasmacytoma

Skull-base plasmacytoma (SBP) is a rare plasma cell neoplasm that typically presents as a slow-growing skull-base lesion in older adults; however, its molecular underpinnings are poorly characterized, limiting targeted therapeutic interventions and precise prognostication. We describe the case of a 67-year-old female who presented with progressive headaches, whose imaging and biopsy confirmed a solitary SBP with no evidence of systemic disease. Whole-exome sequencing revealed an elevated somatic copy number alteration burden and pathogenic variants in <i>ARID1A</i>, <i>KMT2D</i>, <i>BCL7A</i>, <i>PTPN11</i>, and <i>NUP214</i>, suggesting disruptions in chromatin remodeling, B-cell neoplasm pathogenesis, and oncogenic signaling driving the tumorigenesis. These findings provide novel insights into molecular landscape of SBP, highlighting potential for risk stratification and targeted therapy development. The case underscores the importance of comprehensive genomic profiling in rare skull-based tumors to enhance our understanding of their biology and to guide personalized clinical management.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2025-11-25
DOI
https://doi.org/10.3389/fonc.2025.1645502
Primary Topic
Multiple Myeloma Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Case Report: Genomic characterization of a rare skull-base plasmacytoma

D Figuera, Murat Günel, E. Zeynep Erson‐Omay, Sacit Bulent Omay et al.
Frontiers in Oncology
Multiple Myeloma Research and Treatments
article

Case Report: Genomic characterization of a rare skull-base plasmacytoma

D Figuera, Murat Günel, E. Zeynep Erson‐Omay, Sacit Bulent Omay, Ketu Mishra-Gorur, S.R. Kasturi, Deepika Kumar, Kanat Yalcin, Hasan Alanya, Batur Gültekin, Samuel Navarro
article en

Abstract

Skull-base plasmacytoma (SBP) is a rare plasma cell neoplasm that typically presents as a slow-growing skull-base lesion in older adults; however, its molecular underpinnings are poorly characterized, limiting targeted therapeutic interventions and precise prognostication. We describe the case of a 67-year-old female who presented with progressive headaches, whose imaging and biopsy confirmed a solitary SBP with no evidence of systemic disease. Whole-exome sequencing revealed an elevated somatic copy number alteration burden and pathogenic variants in <i>ARID1A</i>, <i>KMT2D</i>, <i>BCL7A</i>, <i>PTPN11</i>, and <i>NUP214</i>, suggesting disruptions in chromatin remodeling, B-cell neoplasm pathogenesis, and oncogenic signaling driving the tumorigenesis. These findings provide novel insights into molecular landscape of SBP, highlighting potential for risk stratification and targeted therapy development. The case underscores the importance of comprehensive genomic profiling in rare skull-based tumors to enhance our understanding of their biology and to guide personalized clinical management.

Frontiers in OncologyVol. 15
Yale University (US)
Yale University, Yale Cancer Center, National Institutes of Health, National Cancer Institute
Openalex Percentile: Top 53%
Multiple Myeloma Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.